CorrlensCorrlens
Correlate

Correlation Analysis

Microsoft Corp vs Incyte Genomics Inc

MSFT vs INCY

+0.062

Weak positive

When one moves up, the other tends to follow.

MSFT logo

Microsoft Corp

MSFT

Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).

Market cap 2.8T

INCY logo

Incyte Genomics Inc

INCY

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

Market cap 18.9B · 2,844 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 observationsStockStockTechnology

Who Moves First

MSFT leads INCY by 6 days

MSFT tends to move before INCY.

Best correlation after shifting: +0.096 (13 shifts scanned)

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.209

11 periods · Return correlation when both series rose

Both Falling

-0.712

7 periods · Return correlation when both series fell

Diverging

-0.588

17 periods · Return correlation when series moved apart

R-Squared

0.4%

Share of variance in one series explained by the other.

Trend Agreement

56.0%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.05

95% CI: [0.006, 0.117]

Time Series

Rebased to 100

Green: MSFTGray: INCY36 of 1,254 points (sampled)

Scatter

XY Regression

208.6250300350400450500549.348.15060708090100106.7Microsoft CorpIncyte Genomics IncData pointsFit (r = 0.062)

Pipeline

Data quality details

Pipeline Summary

1,254 paired observations survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

MSFT logo

Microsoft Corp

MSFT

Market cap 2.8T

Stock · 1,254 raw → 1,254 prepared

Series B

INCY logo

Incyte Genomics Inc

INCY

Market cap 18.9B · 2,844 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

10

Estimated crossover points between normalized spreads.

Slope

0.0089

Linear regression slope.

Intercept

69.4012

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 3 hours ago · ID: stock-msft-vs-stock-incy-daily-20260408-d06k0d